USHER SYNDROME – A GENETIC DISORDER – CAUSED BY MUTATION IN ANY ONE OF THE 11 GENES RESULTING IN COMBINATION OF HEARING LOSS AND VISUAL IMPAIRMENT – DEAFBLINDNESS. HEARING LOSS – A DEFECTIVE INNER EAR. VISION LOSS – RETINITIS PIGMENTATION – A DEGENERATION OF THE RETINAL CELLS. ROD CELLS AFFECTED FIRST – LEADING TO EARLY NIGHT BLINDNESS AND GRADUAL LOSS OF PERIPHERAL VISION . IN OTHER CASES – EARLY DEGENERATING OF THE CONE CELLS IN THE MACULA OCCURS, LEADING TO A LOSS IF CENTRAL ACUITY. IN SOME CASES FOREAL VISION IS SPARED , LEADING TO DOUGNUT VISION, CEREBRAL AND PERIPHERAL VISION ARE INTACT , BUT AN ANNULUS EXISTS AROUND THE CENTRAL REGION IN WHICH VISON IS IMPAIRED.
USHER SYNDROM RESULTS FROM THE LOSS OF A GENER, GENE THERAPY THAT ADDS THE PROPER PROTEIN BACK , GENE REPLACEMENT, MAY ALLEVIATE IT, PROVIDED THE ADDED PROTEIN BECOMES FUNCTIONAL.
THE MEDICINES
USHER SYNDROME IN THE ALTERATION OF A GENE – A GENE THERAPY – A MUTATE – FOR GRADUAL VISION LOSS AND DEFECTIVE EAR – THE THERAPY – A GENE MODELLING – IN A PROTEIN – A TICTAK – A GENE THERAPY – CRYSTONE THERAPY ( CYSTONE THERAPY) - A GENE MODELLING – IN A KINETIC CHANNELING IN A MUCOSE IS A GENE THERAPY – A MUCUS – AN ENERGY – IN A GENE PENETRATION IN THE NANOPARTICLES OF THE DNA – IN A MUCOSE ENERGY – IN A GENE THERAPY AND PROTEIN SYNTHESIS OF A METABOLISM – A CHANNELING IN A KID – IN A METABOLISM AND PROTEIN SYNTHESIS – IN A EAR METABOLISM . AN ENERGY IN A CYSTONE – IN A DNA BARRIER – IN A PROTEIN SYSNTHESIS – INA METABOLISM – IN A RESISTANCE OF DEGENERATED EAR – A DNA CURE IN AN EAR AND EYE – IN A METABOLISM OF GENE THERAPY . CYSTONE PRODUCED – EAR MUTATION – INA GENE THERAPY TO THE RESISTANCE . IN EYE OF EAR – IN A METABOLISM OF A GENE THERAPY – A MUCOSE – A GENE THERAPY – A NUCLEIC ACID – A PENETRATING FORM IN AN ENERGY OF GENES IN A DNA – A REPRESENTATION OF DNA CURE.
BoseMd
Connect With Us